-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Over the past 20 years, topoisomerase inhibitors have been widely used as anti-cancer drugs
DNA topoisomerases are key enzymes for stabilizing DNA hyperpixes and resolving tangles, and are essential
TOP1 inhibitors have been studied extensively, several of which have been approved by
Although the efficacy of TOP1-ADC's TOP1 inhibitors in the treatment of cancer has been greatly improved, there is still a lot of room for improvement in the therapeutic effect of TOP1-ADC (Table 3
Top1 inhibitors have shown considerable potential as anti-tumor therapeutics; However, their poor pharmacokinetics and extra-target toxicity hinder their clinical application
DNA topoisomerases are key enzymes for stabilizing DNA hyperpixes and resolving tangles, and are essential
TOP1 inhibitors have been studied extensively, several of which have been approved by
Although the efficacy of TOP1-ADC's TOP1 inhibitors in the treatment of cancer has been greatly improved, there is still a lot of room for improvement in the therapeutic effect of TOP1-ADC (Table 3
- DNA damage regulator
Top1 inhibitors have shown considerable potential as anti-tumor therapeutics; However, their poor pharmacokinetics and extra-target toxicity hinder their clinical application